These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 21130395

  • 1. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].
    Arroua F, Maurin C, Carcenac A, Ragni E, Rossi D, Bastide C.
    Prog Urol; 2010 Dec; 20(13):1175-83. PubMed ID: 21130395
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ, Gorbonos A, Milner JE, Flanigan RC.
    Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
    [Abstract] [Full Text] [Related]

  • 4. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA, Wood CG.
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V, Matin SF, Wood CG.
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Healy KA, Marshall FF, Ogan K.
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.
    Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R, Motzer R, Kirkali Z, Mulders P, Bellmunt J.
    Eur Urol; 2011 Oct; 60(4):684-90. PubMed ID: 21704448
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma.
    Levy DA, Swanson DA, Slaton JW, Ellerhorst J, Dinney CP.
    J Urol; 1998 Apr; 159(4):1168-73. PubMed ID: 9507824
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?].
    Oya M, Murai M.
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1732-7. PubMed ID: 12402422
    [Abstract] [Full Text] [Related]

  • 19. Surgery for renal cell carcinoma metastases.
    Breau RH, Blute ML.
    Curr Opin Urol; 2010 Sep; 20(5):375-81. PubMed ID: 20592612
    [Abstract] [Full Text] [Related]

  • 20. Cytoreductive nephrectomy: past, present and future.
    Galazi M, Rodriguez-Vida A, Josephides E, Chau NM, Chowdhury S.
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):271-7. PubMed ID: 24392671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.